Association of PD-1 polymorphisms with the risk and prognosis of lung adenocarcinoma in the northeastern Chinese Han population
Abstract Background Lung cancer is a leading cause of death from cancer worldwide, especially non-small cell lung cancer (NSCLC). The marker of progression in lung adenocarcinoma, the main type of NSCLC, has been rarely studied. Programmed death 1 (PD-1) is an effective drug target for the treatment...
Main Authors: | Kun Huang, Erqiang Hu, Wan Li, Junjie Lv, Yuehan He, Gui Deng, Jinling Xiao, Chengcheng Yang, Xinyu Zhao, Lina Chen, Xinyan Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-11-01
|
Series: | BMC Medical Genetics |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12881-019-0914-8 |
Similar Items
-
Relationship Between rs1800896 and rs1465618 Polymorphisms in Prostate Adenocarcinoma in the Iranian Population
by: Golnoosh Tolue, et al.
Published: (2023-10-01) -
PD-1 and PD-L1 expression predict regression and prognosis following neoadjuvant radiochemotherapy of oesophageal adenocarcinoma
by: Holger H. Göbel, et al.
Published: (2022-05-01) -
Investigation of Programmed Cell Death-1 (PD-1) Gene Variations at Positions PD1.3 and PD1.5 in Iranian Patients with Non-small Cell Lung Cancer
by: Zahra Pirdelkhosh, et al.
Published: (2018-01-01) -
Polymorphous Low-Grade Adenocarcinoma
by: Shubhangi Mhaske, et al.
Published: (2010-01-01) -
Polymorphous adenocarcinoma of the parotid – An uncommon site of occurrence
by: Prabhat Mahato, et al.
Published: (2022-01-01)